KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Non-Current Debt (2016 - 2026)

Bausch Health Companies' Non-Current Debt history spans 18 years, with the latest figure at $19.9 billion for Q1 2026.

  • On a quarterly basis, Non-Current Debt fell 6.37% to $19.9 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $19.9 billion, a 6.37% decrease, with the full-year FY2025 number at $20.6 billion, up 8.71% from a year prior.
  • Non-Current Debt hit $19.9 billion in Q1 2026 for Bausch Health Companies, down from $20.6 billion in the prior quarter.
  • Over the last five years, Non-Current Debt for BHC hit a ceiling of $23.2 billion in Q1 2022 and a floor of $18.9 billion in Q4 2024.
  • Historically, Non-Current Debt has averaged $20.9 billion across 5 years, with a median of $20.9 billion in 2025.
  • Biggest five-year swings in Non-Current Debt: dropped 13.66% in 2024 and later rose 8.71% in 2025.
  • Tracing BHC's Non-Current Debt over 5 years: stood at $20.3 billion in 2022, then increased by 7.89% to $21.9 billion in 2023, then dropped by 13.66% to $18.9 billion in 2024, then increased by 8.71% to $20.6 billion in 2025, then dropped by 3.48% to $19.9 billion in 2026.
  • Business Quant data shows Non-Current Debt for BHC at $19.9 billion in Q1 2026, $20.6 billion in Q4 2025, and $20.5 billion in Q3 2025.